Ignite Creation Date:
2025-12-24 @ 4:54 PM
Ignite Modification Date:
2025-12-27 @ 9:14 PM
Study NCT ID:
NCT03036150
Status:
COMPLETED
Last Update Posted:
2021-07-07
First Post:
2017-01-26
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-02-02
Start Date Type:
ACTUAL
Primary Completion Date:
2020-06-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-06-12
Completion Date Type:
ACTUAL
First Submit Date:
2017-01-26
First Submit QC Date:
None
Study First Post Date:
2017-01-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-04-19
Results First Submit QC Date:
None
Results First Post Date:
2021-07-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-06-15
Last Update Post Date:
2021-07-07
Last Update Post Date Type:
ACTUAL